DRD3 and glioblastoma: Considering the inability of TMZ or any treatment to currently provide a GBM cure, our data provide important insights into strategies for DRD antagonism for GBM treatment, although additional studies directly assessing the role of DRD3 through shRNA or CRISPR based approaches are needed.